<?xml version="1.0"?>
<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mods="http://www.loc.gov/mods/v3" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
  <titleInfo>
    <title>Searching for Novel Drug Targets (semester?), IPRO 318: Novel new Drug Targets IPRO 318 Project Plan F06</title>
  </titleInfo>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Kamdar, Amit</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Marell, Joshua</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Knox, John</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Kim, Hyunsuk</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Wu, Calvin</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Polich, Lindsey</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Stankovich, Floriann H.</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Patel, Vrudhdhi</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Jin, Tengchuan</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Desai, Ronak</namePart>
  </name>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Dolejs, Martina</namePart>
  </name>
  <abstract>IPRO 318 is entitled Novel New Drug Targets. The objective for this IPRO is to determine specific proteins that are involved in disease pathology. The team will investigate diseases and their protein sequences in order to determine their function and whether it is suitable for drug targeting. The information collected will be created into an informational website that can be used in further IPRO semesters. With the analyzed data the team will begin testing several relevant sequences to determine drug targeting.</abstract>
  <note type="provenance">Submitted by Ariel True (atrue@iit.edu) on 2011-03-23T17:36:40Z No. of bitstreams: 8 license_rdf: 22564 bytes, checksum: ff373f1ad387898ef8ba4f8bc9e37073 (MD5) license_text: 20904 bytes, checksum: e09bf99e64678e4285abf3ef3e05412d (MD5) Novel new Drug Targets IPRO 318 Project Plan F06.pdf: 22912 bytes, checksum: d41e8183e9e5907cff398657bac2b864 (MD5) Novel new Drug Targets IPRO 318 Poster F06.pdf: 1266951 bytes, checksum: 06903ebbc7f307055d31a745000d7c3c (MD5) Novel new Drug Targets IPRO 318 Midterm Report F06.pdf: 102288 bytes, checksum: e185425d53a16d5a44a372c4df3b9e10 (MD5) Novel new Drug Targets IPRO 318 IPRO Day Presentation F06.pdf: 694949 bytes, checksum: 5daabb9d5cefcd556f3a2bbf64283c38 (MD5) Novel new Drug Targets IPRO 318 Final Report F06.pdf: 94508 bytes, checksum: 9184f61b7dc76341a1cf59ea24848283 (MD5) Novel new Drug Targets IPRO 318 Abstract F06.pdf: 76170 bytes, checksum: 155a6370a453e9f6ca32e500762512eb (MD5)</note>
  <note type="provenance">Approved for entry into archive by Charles Uth(uth@iit.edu) on 2011-03-23T21:48:50Z (GMT) No. of bitstreams: 8 license_rdf: 22564 bytes, checksum: ff373f1ad387898ef8ba4f8bc9e37073 (MD5) license_text: 20904 bytes, checksum: e09bf99e64678e4285abf3ef3e05412d (MD5) Novel new Drug Targets IPRO 318 Project Plan F06.pdf: 22912 bytes, checksum: d41e8183e9e5907cff398657bac2b864 (MD5) Novel new Drug Targets IPRO 318 Poster F06.pdf: 1266951 bytes, checksum: 06903ebbc7f307055d31a745000d7c3c (MD5) Novel new Drug Targets IPRO 318 Midterm Report F06.pdf: 102288 bytes, checksum: e185425d53a16d5a44a372c4df3b9e10 (MD5) Novel new Drug Targets IPRO 318 IPRO Day Presentation F06.pdf: 694949 bytes, checksum: 5daabb9d5cefcd556f3a2bbf64283c38 (MD5) Novel new Drug Targets IPRO 318 Final Report F06.pdf: 94508 bytes, checksum: 9184f61b7dc76341a1cf59ea24848283 (MD5) Novel new Drug Targets IPRO 318 Abstract F06.pdf: 76170 bytes, checksum: 155a6370a453e9f6ca32e500762512eb (MD5)</note>
  <note type="provenance">Made available in DSpace on 2011-03-23T21:48:50Z (GMT). No. of bitstreams: 8 license_rdf: 22564 bytes, checksum: ff373f1ad387898ef8ba4f8bc9e37073 (MD5) license_text: 20904 bytes, checksum: e09bf99e64678e4285abf3ef3e05412d (MD5) Novel new Drug Targets IPRO 318 Project Plan F06.pdf: 22912 bytes, checksum: d41e8183e9e5907cff398657bac2b864 (MD5) Novel new Drug Targets IPRO 318 Poster F06.pdf: 1266951 bytes, checksum: 06903ebbc7f307055d31a745000d7c3c (MD5) Novel new Drug Targets IPRO 318 Midterm Report F06.pdf: 102288 bytes, checksum: e185425d53a16d5a44a372c4df3b9e10 (MD5) Novel new Drug Targets IPRO 318 IPRO Day Presentation F06.pdf: 694949 bytes, checksum: 5daabb9d5cefcd556f3a2bbf64283c38 (MD5) Novel new Drug Targets IPRO 318 Final Report F06.pdf: 94508 bytes, checksum: 9184f61b7dc76341a1cf59ea24848283 (MD5) Novel new Drug Targets IPRO 318 Abstract F06.pdf: 76170 bytes, checksum: 155a6370a453e9f6ca32e500762512eb (MD5) Previous issue date: 2006-12</note>
  <abstract>Deliverables for IPRO 318: Searching for Novel Drug Targets for the Fall 2006 semester</abstract>
  <originInfo>
    <dateCreated keyDate="yes">2006-12</dateCreated>
  </originInfo>
  <originInfo>
    <dateIssued>2006-12</dateIssued>
  </originInfo>
  <identifier type="hdl">http://hdl.handle.net/10560/1656</identifier>
  <language>
    <languageTerm type="code" authority="rfc3066">en</languageTerm>
  </language>
  <subject>
    <topic>Yu Zhu Zhang</topic>
  </subject>
  <subject>
    <topic>Gene-Disease Relationships</topic>
  </subject>
  <subject>
    <topic>Hypothetical Genes</topic>
  </subject>
  <subject>
    <topic>Hypothetical Drug Targets</topic>
  </subject>
  <typeOfResource authority="coar" valueURI="http://purl.org/coar/resource_type/c_18op">Project deliverable</typeOfResource>
  <physicalDescription>
    <digitalOrigin>born digital</digitalOrigin>
    <internetMediaType>application/pdf</internetMediaType>
  </physicalDescription>
  <accessCondition type="useAndReproduction" displayLabel="rightsstatements.org">In Copyright</accessCondition>
  <accessCondition type="useAndReproduction" displayLabel="rightsstatements.orgURI">http://rightsstatements.org/page/InC/1.0/</accessCondition>
  <accessCondition type="restrictionOnAccess">Open Access</accessCondition>
  <name type="corporate">
    <namePart>IPRO / Interprofessional Projects Program</namePart>
    <affiliation>Illinois Institute of Technology</affiliation>
    <role>
      <roleTerm type="text">Affiliated department</roleTerm>
    </role>
  </name>
</mods>
